Libo W. Ruan
157 Jinbi Road
Kunming, 650032, China
Kunming, 650032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
PCK2 Promotes Non-Small Cell Lung Cancer Progression via SLC38A2- Mediated Glutamine Uptake and mTORC1 Activation.
Journal: Current cancer drug targets
Published: July 28, 2025
Phosphoenolpyruvate carboxykinase 2 activation of the AMPK-CEBPB axis to enhance glutamine utilization to promote glycolysis and malignant behavior in adenocarcinomas cells under glucose deprivation.
Journal: Journal of cell communication and signaling
Published: July 13, 2025
Mechanisms and clinical translation of ICOS/ICOSL signaling pathway blockade in delaying vascular complications of type 2 diabetes.
Journal: Diabetology & metabolic syndrome
Published: April 22, 2025
Pulmonary anaplastic lymphoma kinase positive histiocytosis: report of a case
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: October 29, 2023
Knockdown of Malat1 alleviates high-glucose-induced angiogenesis through regulating miR-205-5p/VEGF-A axis.
Journal: Experimental eye research
Published: June 23, 2020
HDAC1 knockdown inhibits invasion and induces apoptosis in non-small cell lung cancer cells.
Journal: Biological chemistry
Published: December 10, 2017
MicroRNA-186 suppresses lung cancer progression by targeting SIRT6.
Journal: Cancer biomarkers : section A of Disease markers
Published: November 11, 2017
Ginsenoside Rb1 inhibits autophagy through regulation of Rho/ROCK and PI3K/mTOR pathways in a pressure-overload heart failure rat model.
Journal: The Journal of pharmacy and pharmacology
Published: October 15, 2017
miR-34a inhibits tumorigenesis of NSCLC via targeting SIRT6.
Journal: International journal of clinical and experimental pathology
Published: December 21, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026